Rounds in the General Hospital March 23, 2023

Acute Psychosis: Differential Diagnosis, Evaluation, and Management

; ; ; ;

Prim Care Companion CNS Disord 2023;25(2):22f03338

LESSONS LEARNED AT THE INTERFACE OF MEDICINE AND PSYCHIATRY

The Psychiatric Consultation Service at Massachusetts General Hospital sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During their twice-weekly rounds, Dr Stern and other members of the Consultation Service discuss diagnosis and management of hospitalized patients with complex medical or surgical problems who also demonstrate psychiatric symptoms or conditions. These discussions have given rise to rounds reports that will prove useful for clinicians practicing at the interface of medicine and psychiatry.

  1. Arciniegas DB. Psychosis. Continuum (Minneap Minn). 2015;21(3 Behavioral Neurology and Neuropsychiatry):715–736. PMC4455840.
  2. Gaebel W, Zielasek J. Focus on psychosis. Dialogues Clin Neurosci. 2015;17(1):9–18. PubMed CrossRef
  3. Gelder M, Andreasen N, Lopez-ibor J, et al. Acute and transient psychotic disorders. In: New Oxford Textbook of Psychiatry. 2012;10:1–16. doi:10.1093/med/9780199696758.001.0001.
  4. Bell V, Raihani N, Wilkinson S. Derationalizing Delusions. Clin Psychol Sci. 2021;9(1):24–37. PubMed CrossRef
  5. Lieberman JA, First MB. Psychotic Disorders. N Engl J Med. 2018;379(3):270–280. PubMed CrossRef
  6. Castagnini A, Galeazzi GM. Acute and transient psychoses: clinical and nosological issues. Br J Psychiatr Adv. 2016;22(5):292–300. CrossRef
  7. Freudenreich O, Holt DJ, Goff DC. Psychotic patients. In: Stern TA, Freudenreich O, Smith FA, et al, eds. Massachusetts General Hospital Handbook of General Hospital Psychiatry. 7th ed. Edinburgh: Elsevier; 2017.
  8. Griswold KS, Del Regno PA, Berger RC. Recognition and differential diagnosis of psychosis in primary care. Am Fam Physician. 2015;91(12):856–863. PubMed
  9. Bojdani E, Zhang T, Shetty S, et al. Hypercalcemia and psychosis: case report, review of the literature, and management considerations. Prim Care Companion CNS Disord. 2018;20(6):18nr02356. PubMed CrossRef
  10. Keshavan MS, Kaneko Y. Secondary psychoses: an update. World Psychiatry. 2013;12(1):4–15. PubMed CrossRef
  11. Wilson JE, Mart MF, Cunningham C, et al. Delirium. Nat Rev Dis Primers. 2020;6(1):90. PubMed CrossRef
  12. Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol. 2009;5(4):210–220. PubMed CrossRef
  13. Fiorentini A, Cantù F, Crisanti C, et al. Substance-induced psychoses: an updated literature review. Front Psychiatry. 2021;12:694863. PubMed CrossRef
  14. Marder S. Psychosis in adults: epidemiology, clinical manifestations, and diagnostic evaluation. UpToDate website. 2021. https://www.uptodate.com/contents/psychosis-in-adults-epidemiology-clinical-manifestations-and-diagnostic-evaluation
  15. Cosci F, Chouinard G. Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychother Psychosom. 2020;89(5):283–306. PubMed CrossRef
  16. Freudenreich O. Secondary schizophrenia. In: Psychotic Disorders: a Practical Guide. 2nd ed. Switzerland: Humana; 2020.
  17. Freudenreich O, Brown HE, Holt DJ. Psychosis and schizophrenia. In: Stern TA, Fava M, Wilens TE, et al, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 2nd ed. Philadelphia, PA: Elsevier; 2016.
  18. Sommer IE, de Kort GA, Meijering AL, et al. How frequent are radiological abnormalities in patients with psychosis? A review of 1379 MRI scans. Schizophr Bull. 2013;39(4):815–819. PubMed CrossRef
  19. Calabrese J, Khalili YA. Psychosis. In: StatPearls. 2022. https://pubmed.ncbi.nlm.nih.gov/31536188/
  20. Byrne P. Managing the acute psychotic episode. BMJ. 2007;334(7595):686–692. PubMed CrossRef
  21. Stilo SA, Murray RM. Non-genetic factors in schizophrenia. Curr Psychiatry Rep. 2019;21(10):100. PubMed CrossRef
  22. Stephen A, Lui F. Brief psychotic disorder; In: StatPearls. 2021. https://pubmed.ncbi.nlm.nih.gov/30969734/
  23. Varchmin L, Montag C, Treusch Y, et al. Traumatic events, social adversity and discrimination as risk factors for psychosis—an umbrella review. Front Psychiatry. 2021;12:665957. PubMed CrossRef
  24. Weisman O, Guri Y, Gur RE, et al; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Subthreshold psychosis in 22q11.2 deletion syndrome: multisite naturalistic study. Schizophr Bull. 2017;43(5):1079–1089. PubMed CrossRef
  25. Heckers S. Who is at risk for a psychotic disorder? Schizophr Bull. 2009;35(5):847–850. PubMed CrossRef
  26. Bromley S, Choi M, Faruqui S. First Episode of Psychosis an Information Guide. Revised Edition. Center for Addiction and Mental Health; 2015.
  27. Perälä J, Suvisaari J, Saarni SI, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 2007;64(1):19–28. PubMed CrossRef
  28. National Institute of Mental Health. Schizophrenia. NIMH website. https://www.nimh.nih.gov/health/statistics/schizophrenia
  29. Cerimele JM, Chwastiak LA, Dodson S, et al. The prevalence of bipolar disorder in general primary care samples: a systematic review. Gen Hosp Psychiatry. 2014;36(1):19–25. PubMed CrossRef
  30. Joseph SM, Siddiqui W. Delusional disorder. In: StatPearls. 2021. https://pubmed.ncbi.nlm.nih.gov/30969677/
  31. Topiwala A, Hothi G, Ebmeier KP. Identifying patients at risk of perinatal mood disorders. Practitioner. 2012;256(1751):15–18, 2. PubMed
  32. Smith MJ, Thirthalli J, Abdallah AB, et al. Prevalence of psychotic symptoms in substance users: a comparison across substances. Compr Psychiatry. 2009;50(3):245–250. PubMed CrossRef
  33. Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394(10202):939–951. PubMed CrossRef
  34. Zhang JP, Gallego JA, Robinson DG, et al. Efficacy and safety of individual second-generation vs first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013;16(6):1205–1218. PubMed CrossRef
  35. Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951–962. PubMed CrossRef
  36. Foley DL, Morley KI. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry. 2011;68(6):609–616. PubMed CrossRef
  37. Hasan A, Falkai P, Wobrock T, et al; World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 2012;13(5):318–378. PubMed CrossRef
  38. Paudel S, Dahal R, Mathias J, et al. Evaluation of risk factors for antipsychotic polypharmacy in inpatient psychiatry units of a community hospital: a retrospective analysis. Community Ment Health J. 2019;55(5):750–754. PubMed CrossRef
  39. Grover S, Sahoo S, Rabha A, et al. ECT in schizophrenia: a review of the evidence. Acta Neuropsychiatr. 2019;31(3):115–127. PubMed CrossRef
  40. Paudel S, Sharma N, Joshi A, et al. Development of a shared decision making model in a community mental health center. Community Ment Health J. 2018;54(1):1–6. PubMed CrossRef
  41. Zimbroff DL. Management of acute psychosis: from emergency to stabilization. CNS Spectr. 2003;8(suppl 2):10–15. PubMed CrossRef
  42. Wong AH, Ray JM, Rosenberg A, et al. Experiences of individuals who were physically restrained in the emergency department. JAMA Netw Open. 2020;3(1):e1919381. PubMed CrossRef
  43. Wright A, Browne J, Mueser KT, et al. Evidence-based psychosocial treatment for individuals with early psychosis. Child Adolesc Psychiatr Clin N Am. 2020;29(1):211–223. PubMed CrossRef
  44. Morrison AP, Pyle M, Maughan D, et al; MAPS group. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study. Lancet Psychiatry. 2020;7(9):788–800. PubMed CrossRef
  45. Dixon LB, Dickerson F, Bellack AS, et al; Schizophrenia Patient Outcomes Research Team (PORT). The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010;36(1):48–70. PubMed CrossRef
  46. Addington D, Abidi S, Garcia-Ortega I, et al. Canadian guidelines for the assessment and diagnosis of patients with schizophrenia spectrum and other psychotic disorders. Can J Psychiatry. 2017;62(9):594–603. PubMed CrossRef